Could a common supplement ease 'Chemo Brain' for ovarian cancer patients?
NCT ID NCT04520139
Summary
This study is testing whether adding the supplement N-Acetyl-Cysteine (NAC) to standard platinum-based chemotherapy can help reduce memory and thinking problems, often called 'chemo brain,' in women with ovarian cancer. The first part of the study will find the safest dose of NAC, and the second part will explore if that dose helps patients' cognitive function. It will involve about 102 women with advanced ovarian cancer who are scheduled for at least six cycles of chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.